| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 3.84% | Morgan Stanley | $162 → $154 | Maintains | Equal-Weight |
| 10/16/2023 | 1.82% | JP Morgan | → $151 | Upgrades | Underweight → Neutral |
| 09/08/2023 | 1.82% | JP Morgan | $150 → $151 | Maintains | Underweight |
| 07/27/2023 | 21.38% | Citigroup | $160 → $180 | Maintains | Neutral |
| 07/26/2023 | 9.24% | Morgan Stanley | $148 → $162 | Maintains | Equal-Weight |
| 07/11/2023 | 12.61% | Credit Suisse | $156 → $167 | Maintains | Outperform |
| 07/05/2023 | 28.79% | Exane BNP Paribas | → $191 | Upgrades | Neutral → Outperform |
| 06/21/2023 | -0.2% | Morgan Stanley | → $148 | Reiterates | → Equal-Weight |
| 06/01/2023 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
| 05/23/2023 | -12.34% | JP Morgan | → $130 | Initiates Coverage On | → Underweight |
| 05/22/2023 | -0.2% | Morgan Stanley | $133 → $148 | Maintains | Equal-Weight |
| 04/24/2023 | -10.32% | Morgan Stanley | $131 → $133 | Maintains | Equal-Weight |
| 03/20/2023 | -11.67% | Morgan Stanley | $122 → $131 | Maintains | Equal-Weight |
| 03/17/2023 | 5.19% | Credit Suisse | $140 → $156 | Maintains | Outperform |
| 03/13/2023 | 8.56% | Goldman Sachs | $144 → $161 | Maintains | Neutral |
| 03/10/2023 | 8.56% | Goldman Sachs | $144 → $161 | Maintains | Neutral |
| 01/30/2023 | -17.73% | Morgan Stanley | $113 → $122 | Maintains | Equal-Weight |
| 01/27/2023 | 11.26% | BMO Capital | $155 → $165 | Maintains | Market Perform |
| 01/04/2023 | 15.98% | B of A Securities | → $172 | Reinstates | → Buy |
| 12/06/2022 | -2.23% | UBS | $120 → $145 | Maintains | Neutral |
| 11/09/2022 | -4.25% | BMO Capital | $113 → $142 | Maintains | Market Perform |
| 10/24/2022 | -23.8% | Morgan Stanley | $115 → $113 | Maintains | Equal-Weight |
| 10/06/2022 | -23.13% | Goldman Sachs | $127 → $114 | Maintains | Neutral |
| 09/16/2022 | -5.6% | Credit Suisse | $165 → $140 | Maintains | Outperform |
| 07/25/2022 | -22.45% | Morgan Stanley | $121 → $115 | Maintains | Equal-Weight |
| 07/06/2022 | -18.41% | Morgan Stanley | $144 → $121 | Maintains | Equal-Weight |
| 06/14/2022 | -15.71% | JP Morgan | $146 → $125 | Maintains | Neutral |
| 05/31/2022 | -12.34% | Goldman Sachs | $148 → $130 | Maintains | Neutral |
| 05/11/2022 | -2.9% | Morgan Stanley | $108 → $144 | Maintains | Equal-Weight |
| 04/25/2022 | 28.12% | Argus Research | $140 → $190 | Maintains | Buy |
| 04/22/2022 | -0.2% | Goldman Sachs | $134 → $148 | Maintains | Neutral |
| 04/22/2022 | 18% | Credit Suisse | $142 → $175 | Maintains | Outperform |
| 03/24/2022 | -13.01% | JP Morgan | $113 → $129 | Maintains | Neutral |
| 02/16/2022 | -19.08% | Goldman Sachs | $114 → $120 | Maintains | Neutral |
| 01/31/2022 | -27.17% | Morgan Stanley | $107 → $108 | Maintains | Equal-Weight |
| 01/11/2022 | -31.22% | Wolfe Research | → $102 | Downgrades | Peer Perform → Underperform |
| 11/17/2021 | -29.87% | Wolfe Research | → $104 | Initiates Coverage On | → Peer Perform |
| 10/26/2021 | -27.85% | Morgan Stanley | $105 → $107 | Maintains | Equal-Weight |
| 10/06/2021 | -27.17% | Goldman Sachs | $123 → $108 | Downgrades | Buy → Neutral |
| 09/15/2021 | -12.34% | Deutsche Bank | $100 → $130 | Maintains | Hold |
| 08/24/2021 | -12.34% | Seaport Global | → $130 | Initiates Coverage On | → Buy |
| 07/01/2021 | -32.57% | Deutsche Bank | $75 → $100 | Maintains | Hold |
| 06/16/2021 | -23.13% | JP Morgan | → $114 | Initiates Coverage On | → Neutral |
| 06/14/2021 | -31.89% | Morgan Stanley | $95 → $101 | Maintains | Equal-Weight |
| 05/11/2021 | -35.94% | Morgan Stanley | $71 → $95 | Maintains | Equal-Weight |
| 04/20/2021 | -46.06% | B of A Securities | $56 → $80 | Upgrades | Underperform → Neutral |
| 04/12/2021 | — | Goldman Sachs | Initiates Coverage On | → Buy | |
| 04/09/2021 | -42.01% | Goldman Sachs | → $86 | Initiates Coverage On | → Buy |
| 03/19/2021 | -42.68% | Argus Research | → $85 | Upgrades | Hold → Buy |
| 03/12/2021 | -52.12% | Morgan Stanley | $60 → $71 | Maintains | Equal-Weight |
| 02/03/2021 | -57.52% | Credit Suisse | → $63 | Upgrades | Neutral → Outperform |
| 12/09/2020 | -59.54% | Morgan Stanley | → $60 | Initiates Coverage On | → Equal-Weight |
| 11/20/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 10/15/2020 | -67.63% | Exane BNP Paribas | → $48 | Downgrades | Outperform → Neutral |
| 08/11/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 06/10/2020 | -66.96% | Keybanc | $45 → $49 | Maintains | Overweight |
| 05/14/2020 | -73.7% | UBS | $56 → $39 | Maintains | Neutral |
| 05/13/2020 | -69.66% | Keybanc | $49 → $45 | Maintains | Overweight |
| 04/29/2020 | -71.68% | BMO Capital | $35 → $42 | Maintains | Market Perform |
| 04/17/2020 | -71.68% | JP Morgan | $57 → $42 | Maintains | Overweight |
| 03/30/2020 | -72.35% | Goldman Sachs | $55 → $41 | Upgrades | Neutral → Buy |
| 03/24/2020 | -71% | Keybanc | $60 → $43 | Maintains | Overweight |
| 03/20/2020 | -63.59% | Credit Suisse | $57 → $54 | Maintains | Outperform |
| 02/18/2020 | -59.54% | Keybanc | $62 → $60 | Maintains | Overweight |
| 01/31/2020 | -62.91% | Goldman Sachs | $60 → $55 | Downgrades | Buy → Neutral |
| 01/29/2020 | -61.56% | Credit Suisse | $61 → $57 | Maintains | Outperform |
| 01/29/2020 | — | Deutsche Bank | Downgrades | Hold → Sell | |
| 12/09/2019 | — | Longbow Research | Upgrades | Neutral → Buy | |
| 11/14/2019 | -62.24% | UBS | $57 → $56 | Maintains | Neutral |
| 11/13/2019 | -58.19% | Keybanc | $60 → $62 | Maintains | Overweight |
| 08/27/2019 | -59.54% | Keybanc | $61 → $60 | Maintains | Overweight |
| 06/17/2019 | -58.87% | Keybanc | $66 → $61 | Maintains | Overweight |
| 06/04/2019 | -60.22% | Goldman Sachs | $70 → $59 | Maintains | Buy |
| 05/31/2019 | -66.28% | B of A Securities | $68 → $50 | Downgrades | Buy → Underperform |
| 05/22/2019 | -55.5% | Keybanc | $70 → $66 | Maintains | Overweight |
| 03/11/2019 | — | Longbow Research | Downgrades | Buy → Neutral | |
| 01/09/2019 | -58.19% | Cowen & Co. | → $62 | Initiates Coverage On | → Outperform |
| 01/08/2019 | — | Credit Suisse | Upgrades | Neutral → Outperform |
What is the target price for Nucor (NUE)?
The latest price target for Nucor (NYSE: NUE) was reported by Morgan Stanley on October 31, 2023. The analyst firm set a price target for $154.00 expecting NUE to rise to within 12 months (a possible 3.84% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nucor (NUE)?
The latest analyst rating for Nucor (NYSE: NUE) was provided by Morgan Stanley, and Nucor maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Nucor (NUE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nucor, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nucor was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
Is the Analyst Rating Nucor (NUE) correct?
While ratings are subjective and will change, the latest Nucor (NUE) rating was a maintained with a price target of $162.00 to $154.00. The current price Nucor (NUE) is trading at is $148.30, which is out of the analyst's predicted range.